Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Yue Zeng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7275-9978; OpenAlex author ID A5101607185. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Retraction Note: Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s13046-023-02595-3↗
  2. [MiR-183 Regulates Proliferation of SW1990 Pancreatic Cancer Cell Line by Targeting PDCD4]. First author PMID 28598081↗
  3. miR-183 induces cell proliferation, migration, and invasion by regulating PDCD4 expression in the SW1990 pancreatic cancer cell line. Last author DOI 10.1016/j.biopha.2015.01.016↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xingpeng Wang · 2 shared papers, 2016–2023 · strength 0.25
  2. Li Huang · 1 shared paper, 2023 · strength 0.17
  3. Congying Chen · 1 shared paper, 2023 · strength 0.17
  4. Guoyong Hu · 1 shared paper, 2023 · strength 0.17
  5. Lijuan Yang · 1 shared paper, 2023 · strength 0.17
  6. Yingying Lu · 2 shared papers, 2015–2016 · strength 0.14
  7. Wei Zhang · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.